LUPUS NEPHRITIS
Clinical trials for LUPUS NEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new LUPUS NEPHRITIS trials appear
Sign up with your email to follow new studies for LUPUS NEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lupus drug shows promise in reducing kidney damage
Disease control CompletedThis study tested an experimental drug called KZR-616 in 69 people with lupus, some of whom also had lupus-related kidney disease (lupus nephritis). The goal was to see if the drug is safe and can help control the disease by reducing protein in the urine, a sign of kidney damage.…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated May 17, 2026 07:54 UTC
-
New hope for lupus patients: drug shows promise for kidney protection
Disease control CompletedThis study tested an experimental drug called BI 655064 in 121 people with active lupus nephritis, a serious kidney complication of lupus. The goal was to see if adding this drug to standard treatment could improve kidney function after one year. Participants received one of thre…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated May 17, 2026 07:52 UTC
-
Which drug wins for lupus kidney disease? new study pits telitacicept against belimumab
Disease control CompletedThis study looked back at medical records of 56 adults with lupus nephritis to compare two drugs: telitacicept and belimumab. The goal was to see which one better protects kidney function and causes fewer side effects. Participants had already been on one of the drugs for at leas…
Matched conditions: LUPUS NEPHRITIS
Sponsor: Yipeng Liu • Aim: Disease control
Last updated May 17, 2026 07:36 UTC
-
New drug shows promise for lupus kidney patients in china
Disease control CompletedThis study tested a drug called efgartigimod in 73 Chinese adults with active lupus nephritis, a kidney disease caused by lupus. The goal was to see if the drug could reduce protein in the urine and improve kidney function over 24 weeks. Participants received either the drug or a…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE2 • Sponsor: argenx • Aim: Disease control
Last updated May 11, 2026 20:38 UTC
-
Taiwan study checks safety of common lupus kidney drug
Disease control CompletedThis study followed 72 adults in Taiwan with lupus nephritis who were taking Myfortic (mycophenolate sodium) for the first time. Over 12 months, researchers tracked side effects, serious events, and reasons for stopping the drug. The goal was to understand how safe this treatment…
Matched conditions: LUPUS NEPHRITIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:37 UTC
-
New hope for lupus patients: which drug combo wins for kidney health?
Disease control CompletedThis study tested two different medicine combinations to treat lupus nephritis, a kidney disease caused by lupus. 130 adults with active kidney inflammation took either tacrolimus plus steroids or mycophenolate mofetil plus steroids. The goal was to see which combo better improve…
Matched conditions: LUPUS NEPHRITIS
Phase: PHASE3 • Sponsor: The University of Hong Kong • Aim: Disease control
Last updated May 05, 2026 11:54 UTC
-
New clue for lupus kidney disease: a simple antibody test?
Knowledge-focused CompletedThis study looked at whether a specific antibody (anti-GBM) in the blood can help identify lupus patients who have kidney inflammation (lupus nephritis). Researchers tested stored blood samples from 100 people with lupus and healthy donors. The goal was to see if this antibody is…
Matched conditions: LUPUS NEPHRITIS
Phase: NA • Sponsor: CHU de Reims • Aim: Knowledge-focused
Last updated May 17, 2026 07:36 UTC